Literature DB >> 23084100

Should all moderate coronary lesions be grafted during primary coronary bypass surgery? An analysis of progression of native vessel disease during a randomized trial of conduits.

Philip A Hayward1, Ying Yan Zhu, Trong T Nguyen, David L Hare, Brian F Buxton.   

Abstract

OBJECTIVE: Whether to graft a moderately stenosed coronary vessel remains debatable. We investigated whether grafting such vessels is warranted based on angiographic evidence of disease progression.
METHODS: Of 619 patients who underwent on-pump coronary artery bypass grafting in an ongoing, randomized radial artery trial, 405 have at least 1 follow-up angiogram at a mean of 6.2 ± 3.1 years (range, 0-14 years) after surgery. Percent diameter stenosis in each major native vessel was reported by 3 cardiac specialists and classified as either moderate (40%-69%) or severe (≥70%) stenosis. Progression of native vessel disease and graft patency were determined by comparison of pre- and postoperative angiography.
RESULTS: A total of 3816 native vessels and 1242 bypass grafts were analyzed, of which 386 moderate preoperative lesions were identified, 323 of which were grafted. In all territories, grafted vessels had greater risk of disease progression than ungrafted equivalents (43.4% vs 10.5%, P < .001). Moderate lesions were more likely than severe lesions to remain unchanged on follow-up angiography (52.6% vs 31.1%, P < .001). Only 1 in 7 moderate lesions in the right coronary artery exhibited significant progression during follow-up if left ungrafted, whereas the likelihood of progression in left-sided counterparts approached 50%. Arterial and vein grafts to left-sided moderately stenosed vessels had excellent patency (83% and 77% at 8 years, respectively), which was not matched by right-sided grafts (P = .051). Placement of a graft for a moderate lesion was associated with significantly greater incidence of disease progression, most marked in the right coronary territory.
CONCLUSIONS: The greater risk of progression of left-sided moderate lesions, and high graft patency rates when bypassed, suggests that the balance of clinical judgment lies in favor of grafting moderate left-sided lesions. In the right coronary system, however, a lesion is likely to remain moderate if left ungrafted and, with a low risk of progression, it may be reasonable to leave these vessels undisturbed. Crown
Copyright © 2013. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23084100     DOI: 10.1016/j.jtcvs.2012.09.050

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  Outcomes of chronic total occlusion percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the LATAM CTO registry.

Authors:  Dagmar F Hernandez-Suarez; Lorenzo Azzalini; Francesco Moroni; João Eduardo Tinoco de Paula; Pablo Lamelas; Carlos M Campos; Marcelo Harada Ribeiro; Evandro Martins Filho; Felix Damas de Los Santos; Lucio Padilla; Marco Alcantara-Melendez; Marcelo A Abud; Israel A Almodóvar-Rivera; Marcia Moura Schmidt; Mauro Echavarria; Antonio Carlos Botelho; Valentin Del Rio; Alexandre Quadros; Ricardo Santiago
Journal:  Catheter Cardiovasc Interv       Date:  2021-12-20       Impact factor: 2.692

2.  Does grafting coronary arteries with only moderate stenosis affect long-term mortality?

Authors:  Joseph F Sabik; Gabriel Olivares; Sajjad Raza; Bruce W Lytle; Penny L Houghtaling; Eugene H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-23       Impact factor: 5.209

3.  CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.

Authors:  Robert H Habib; Kamellia R Dimitrova; Sanaa A Badour; Maroun B Yammine; Abdul-Karim M El-Hage-Sleiman; Darryl M Hoffman; Charles M Geller; Thomas A Schwann; Robert F Tranbaugh
Journal:  J Am Coll Cardiol       Date:  2015-09-29       Impact factor: 24.094

4.  The art of arterial revascularization-total arterial revascularization in patients with triple vessel coronary artery disease.

Authors:  Brian F Buxton; Philip A Hayward
Journal:  Ann Cardiothorac Surg       Date:  2013-07

5.  Mid-term results of the Radial Artery Patency and Clinical Outcomes randomized trial.

Authors:  Philip A Hayward; Brian F Buxton
Journal:  Ann Cardiothorac Surg       Date:  2013-07

Review 6.  Conduits for coronary bypass: strategies.

Authors:  Hendrick B Barner
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-10-04

7.  Prophylactic Left Internal Mammary Artery Graft In Mildly-Stenosed Coronary Lesions. Still An Open Discussion.

Authors:  Paulo Roberto B Evora; Livia Arcêncio; André Schmidt; Alfredo José Rodrigues
Journal:  Arq Bras Cardiol       Date:  2016-03       Impact factor: 2.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.